SCHEMBL4190708

SCHEMBL4190708

N#CCC1C=CN=C(NCCN2CCOCC2)N1c1nc2ccccc2s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 3/20 0.48
GAA P10253 2/20 0.48
ILK Q13418 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
TSHR P16473 2/20 0.41
ALDH1A1 P00352 3/20 0.40
IRAK4 Q9NWZ3 4/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
CLK4 Q9HAZ1 2/20 0.39
ACP1 P24666 1/20 0.39
TOP2A P11388 1/20 0.38
IDO1 P14902 1/20 0.38
LTA4H P09960 1/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4192267 0.95 GAA (0.46) USP2GAAILKSMN1; SMN2RAB9A
SCHEMBL4187928 0.91 ILK (0.41) USP2GAAILKALDH1A1IRAK4
SCHEMBL4197516 0.85 IRAK4 (0.39) USP2GAASMN1; SMN2RAB9ANPC1
SCHEMBL4195581 0.84 USP2 (0.52) USP2GAAILKSMN1; SMN2RAB9A
SCHEMBL4187924 0.84 RAB9A (0.36) USP2GAASMN1; SMN2RAB9ANPC1
SCHEMBL4192273 0.84 MAPK9 (0.39) ILKSMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL4186367 0.82 ILK (0.37) GAAILKALDH1A1KDM4EGLA
SCHEMBL4192472 0.82 NPC1 (0.46) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
Acetonitrile SCHEMBL7707679 0.82 RAB9A (0.35) USP2GAASMN1; SMN2RAB9ANPC1
SCHEMBL4187935 0.81 ILK (0.38) ILKSMN1; SMN2RAB9ANPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2026802-A2 JNK INHIBITORS FOR TREATMENT OF SKIN DISEASES Laboratoires Serono SA (CH) 2009-02-25 EP disclosed
WO-2007141224-A2 JNK INHIBITORS FOR TREATMENT OF SKIN DISEASES LABORATOIRES SERONO SA (CH) 2007-12-13 WO disclosed